Japan approves subcutaneous autoinjector form of Leqembi for Alzheimer's

Go back to Japan approves subcutaneous autoinjector form of Leqembi for Alzheimer's
BARNES GROUP, Inc. (NYSE: B) Delayed: 40.59 +0.16 (0.40%)
Previous Close $40.43    52 Week High $44.27 
Open $40.82    52 Week Low $30.07 
Day High $40.88    P/E 30.98 
Day Low $40.46    EPS $1.31 
Volume 1,828,954       

BIOAMBER, Inc. (NASDAQ: BIOA) Delayed: 5.52 -0.04 (0.72%)
Previous Close $5.56    52 Week High $8.73 
Open $5.61    52 Week Low $2.86 
Day High $5.70    P/E N/A 
Day Low $5.43    EPS $-3.82 
Volume 186,230